Patents Assigned to Boehringer Ingelheim Internationational GmbH
  • USE OF MNK INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20100247517
    Abstract: The present invention relates to the use of modulators of the kinase activity of Mnk1 and/or Mnk2 the diagnosis, alleviation, treatment and/or prevention of a tauopathy. Particularly, the present invention relates to the use of a modulator of Mnk1 and/or Mnk2 kinase for the diagnosis, alleviation, treatment and/or prevention of Alzheimer's disease. Preferably, the compounds are condensed pyrimidines.
    Type: Application
    Filed: November 21, 2008
    Publication date: September 30, 2010
    Applicant: Boehringer Ingelheim Internationational GmbH
    Inventors: Matthias Austen, Marcus Geese, Martin Schneider